Topics: COVID-19
Events
-
-
AAHMS webinar – COVID-19: Where to from here?
-
Tweetchats with PRAXIS and ACTA
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
-
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
News
-
State and Territory Clinical Trials Contacts
-
FIND AND SHARE CLINICAL TRIAL SOLUTIONS AT BEYOND COVID-19: A SOLUTION-FOCUSSED FORUM
-
HealthMatch Clinical Trials Tracker – See clinical trials in action during the COVID-19 pandemic
-
Victorian Coordinating Office for Clinical Trial Research update
-
Vaccines alone won’t keep Australia COVID-safe, review finds
-
MHRA guidance on managing clinical trials during Coronavirus (COVID19)
-
NHMRC extensions due to COVID-19 impact on researchers
-
The UK’s EPPI-Centre has released a list of COVID-19 resources
-
ACTA statement on COVID-19
-
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
-
Medical Research Future Fund – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity open for applications – urgent call for research
-
Australian Commission on Safety and Quality in Health Care Health Service Accreditation (AHSSQA) during the COVID-19 pandemic
-
COVID-19 Expert Database
-
Tweetchats with PRAXIS and ACTA
-
Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency: Guidance for Industry
-
NHMRC advice regarding grant administration matters
-
New South Wales Office for Health and Medical Research COVID-19 Guidance
-
Australian Commission on Safety and Quality in Health Care extends timeline for National Clinical Trials Governance Pilot due to COVID-19 pandemic
-
PRAXIS Managing Clinical Trials webinar recording now available
-
COVID-19 and clinical trial updates
-
National Medical Stockpile: Supply of experimental medicines to support clinical trials
-
ARCS Webinar Series: COVID-19: considerations and strategies for running trials during the pandemic
-
ClinTrial Refer COVID-19 app access
-
JAMA recommendations on maintaining clinical trial integrity during COVID-19 pandemic